Nonsteroidal anti-inflammatory drugs: problems of safe use
https://doi.org/10.30895/2312-7821-2018-6-1-11-18
Abstract
About the Authors
N. Yu. VeltsRussian Federation
Velts Natalia Yu. Senior Analyst of the Research and Methodology Department of the DEMPS. PhD.
E. O. Zhuravleva
Russian Federation
Zhuravleva Eugenia O. Head of the Department of Science and Analysis Department of the DEMPS.
T. M. Bukatina
Russian Federation
Bukatina Tatyana M. Senior Analyst of the Research and Methodology Department of the DEMPS. PhD.
G. V. Kutekhova
Russian Federation
Kutekhova Galina V. Analyst of the 1st category of the Department of Science and Analysis Department of the DEMPS.
References
1. Amelin AV, Volchkov VA, Dmitriev VA, et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs. Ed. YuD Ignatova, VG Kukesa, VI Mazurov. Moscow: GEOTAR Media; 2010. (In Russ.).
2. Fokina NM, Dudnik EN. NSAIDs: systemic and local application (specialist choice). Russian Medical Journal 2013; 6: 320-321. (In Russ.).
3. Karateev AE. Modification of traditional NSAIDs as a method of increasing their safety and ease of use. Russian Medical Journal 2015; 7: 392-398. (In Russ.).
4. Karateev AE, Uspensky YP, Pakhomova IG, Nasonov EL. A concise course of the history of NSAIDs. Rheumatology Science and Practice. 2012; 50(3): 101-116. (In Russ.).
5. Pharmacology. Ed. RN Alautdin. Moscow: GEOTAR Media; 2004. (In Russ.).
6. Karateev AE. What is better for the prevention of NSAIDs-gastropathy: coxibs or a combination of «traditional» NSAIDs and gastroprotector? Russian Medical Journal 2013; 13: 673-680. (In Russ.).
7. Schwartz GYa. Pharmacogenetic features of the metabolism of modern NSAIDs and the risk of gastro-toxic complications. Medicines: applied pharmacology and personalized pharmacotherapy 2010; 1(1): 65-70. (In Russ.).
8. Krasnykh LM, Smirnov VV, Vasilenko GF, Goroshko OA, Egorenkov EA, Zozina VI. Differences in the pharmacokinetics of ibuprofen in mono- and multicomponent drugs. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Prodacts 2017; 7(2): 117-121. (In Russ).
9. Kazakov AS, Zatolochina KE, Romanov BK, Bukatina TM, Velts NYu. The risk management system is an important part of the Good Pharmacovigilance Practices (GVP) Rules. Safety and Risk of Pharmacotherapy. 2016; 1: 21-27. (In Russ.).
10. Romanov BK, Toropova II, Kolesnikova EYu. Medication errors. Safety and Risk of Pharmacotherapy 2014; 2(3): 28-30. (In Russ.).
11. Federal Law of April 12, 2010 No 61-FZ «On the circulation of medicine» [Internet]. 2017 (cited 04 December 2017). Available from: https:// http://www.rg.ru/2010/04/14/lekarstva-dok.html (In Russ.).
12. Avdeev SN, Avedisova AS, Avetisov SE et al. Federal guidance on the use of drugs (formulary system). Ser. Library of the Russian national Congress «Man and medicine». Release of the XVIII (18th Edition, revised and enlarged). Moscow: 2017. (In Russ.).
Review
For citations:
Velts N.Yu., Zhuravleva E.O., Bukatina T.M., Kutekhova G.V. Nonsteroidal anti-inflammatory drugs: problems of safe use. Safety and Risk of Pharmacotherapy. 2018;6(1):11-18. (In Russ.) https://doi.org/10.30895/2312-7821-2018-6-1-11-18